Healthcare - Biotechnology - NASDAQ - US
$ 2.84
-5.8 %
$ 326 M
Market Cap
-3.05
P/E
BALANCE SHEET
217 M
ASSETS
41.1 M
LIABILITIES
176 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Absci Corporation
| Current Assets | 121 M |
| Cash & Short-Term Investments | 97.7 M |
| Receivables | 2.19 M |
| Other Current Assets | 20.7 M |
| Non-Current Assets | 96.7 M |
| Long-Term Investments | 0 |
| PP&E | 45.8 M |
| Other Non-Current Assets | 50.9 M |
| Current Liabilities | 29.6 M |
| Accounts Payable | 1.5 M |
| Short-Term Debt | 5.58 M |
| Other Current Liabilities | 22.5 M |
| Non-Current Liabilities | 11.6 M |
| Long-Term Debt | 10.4 M |
| Other Non-Current Liabilities | 1.18 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 72.4 | 60.0 | 252.6 | 69.9 | 13.1 |
| Short Term Investments | 25.3 | 104.5 | 0 | 0 | 0 |
| Receivables | 2.2 | 1.6 | 1.4 | 1.6 | 0.2 |
| Inventory | 0 | 15.0 | 10.5 | 1 | 1 |
| Other Current Assets | 20.7 | 26.7 | 19.1 | 1.8 | 0.3 |
| Total Current Assets | 120.6 | 186.9 | 273.1 | 73.2 | 13.6 |
| PP&E | 45.8 | 58.0 | 58.7 | 13.4 | 5.0 |
| Intangible Assets | 48.3 | 51.6 | 55.0 | 0.2 | 0.3 |
| Goodwill | 0 | 21.3 | 21.3 | 0 | 0 |
| Long Term Investments | 0 | 1.9 | 16.8 | 1.8 | 0.8 |
| Other Long Term Assets | 2.6 | (16.4) | 18.1 | 1.8 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 217.3 | 321.0 | 426.2 | 88.6 | 19.5 |
| LIABILITIES | |||||
| Accounts Payable | 1.5 | 2.4 | 8.4 | 2.1 | 0.3 |
| Short Term Debt | 5.6 | 6.9 | 11.0 | 3.8 | 1.9 |
| Other Current Liabilities | 32.1 | 33.2 | 13.1 | 1.6 | 0.5 |
| Total Current Liabilities | 29.6 | 30.3 | 33.9 | 10.1 | 3.5 |
| Long Term Debt | 10.4 | 16.1 | 13.3 | 10.7 | 4.1 |
| Deferred Tax Income | 0.2 | 0.2 | 0.7 | 0 | 0 |
| Other Liabilities | 33 K | 35 K | 12.2 | 157.2 | 53.0 |
| Total Liabilities | 41.1 | 46.6 | 60.1 | 178.0 | 60.6 |
| EQUITY | |||||
| Common Stock | 9 K | 9 K | 9 K | 2 K | 2 K |
| Retained Earnings | (406.5) | (295.9) | (191.0) | (90.1) | (41.4) |
| Other Accumulative Comprehensive Income/Loss | 37 K | (0.1) | 13 K | (156.4) | (52.8) |
| Total Equity | 176.2 | 274.4 | 366.1 | (89.4) | (41.2) |
| Total Liabilities and Equity | 217.3 | 321.0 | 426.2 | 88.6 | 19.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 92.0 | 90.8 | 92.6 | 92.3 | 92.3 |